SARS-CoV-2 nsp16 is regulated by host E3 ubiquitin ligases, UBR5 and MARCHF7
eLife · 2025
DOI: 10.7554/elife.102277 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2025. Verfasst von Li Tian und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Infectious Diseases and Pathogen Biology Center, Institute of Virology and AIDS Research, Key Laboratory of Organ …. Hauptthemen laut MEDLINE: Ubiquitin-Protein Ligases, SARS-CoV-2, Viral Nonstructural Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Science and Technology Department of Jilin Province.
Abstract (Originalsprache)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), remains a global public health threat with considerable economic consequences. The nonstructural protein 16 (nsp16), in complex with nsp10, facilitates the final viral mRNA capping step through its 2′- O -methylase activity, helping the virus to evade host immunity and prevent mRNA degradation. However, nsp16 regulation by host factors remains poorly understood. While various E3 ubiquitin ligases interact with SARS-CoV-2 proteins, their roles in targeting nsp16 for degradation remain unclear. In this study, we demonstrate that nsp16 undergoes ubiquitination and proteasomal degradation mediated by the host E3 ligases UBR5 and MARCHF7. UBR5 induces K48-linked ubiquitination, whereas MARCHF7 promotes K27-linked ubiquitination, independently suppressing SARS-CoV-2 replication in cell cultures and in mice. Notably, UBR5 and MARCHF7 also degrade nsp16 variants from different viral strains, exhibiting broad-spectrum antiviral activity. Our findings reveal novel antiviral mechanisms of the ubiquitin-proteasome system (UPS) and highlight their potential therapeutic targets against COVID-19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, Infectious Diseases and Pathogen Biology Center, Institute of Virology and AIDS Research, Key Laboratory of Organ Regeneration and Transplantation of The Ministry of Education, The Fir…
- Research Unit of Key Technologies for Prevention and Control of Virus Zoonoses, Chinese Academy of Medical Sciences, Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.
ORCID-Profile: Li Tian, Wenyan Zhang, Zhaolong Li
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Science and Technology Department of Jilin Province
- Key Laboratory of Molecular Virology, Jilin Province
- Jilin University
Zitieren
APA
Tian, L., Zhao, Z., Gao, W., Liu, Z., Li, X., Zhang, W., & Li, Z. (2025). SARS-CoV-2 nsp16 is regulated by host E3 ubiquitin ligases, UBR5 and MARCHF7. eLife. https://doi.org/10.7554/elife.102277
Vancouver
Tian L, Zhao Z, Gao W, Liu Z, Li X, Zhang W, et al. SARS-CoV-2 nsp16 is regulated by host E3 ubiquitin ligases, UBR5 and MARCHF7. eLife. 2025. doi:10.7554/elife.102277
BibTeX
@article{Tian2025,
author = {Tian, Li and Zhao, Zongzheng and Gao, Wenying and Liu, Zirui and Li, Xiao and Zhang, Wenyan and Li, Zhaolong},
title = {SARS-CoV-2 nsp16 is regulated by host E3 ubiquitin ligases, UBR5 and MARCHF7},
journal = {eLife},
year = {2025},
doi = {10.7554/elife.102277}
}
EUVIMED